These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 3497133)
1. T cell subsets involved in the rejection of metastases arising from intraocular melanomas in mice. Niederkorn JY Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1397-403. PubMed ID: 3497133 [TBL] [Abstract][Full Text] [Related]
2. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice. Niederkorn JY Invest Ophthalmol Vis Sci; 1984 Sep; 25(9):1080-6. PubMed ID: 6381375 [TBL] [Abstract][Full Text] [Related]
3. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. Niederkorn JY; Streilein JW J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396 [TBL] [Abstract][Full Text] [Related]
4. Immune rejection of metastases arising from intraocular tumors in mice. Niederkorn JY; Knisely TL; Mayhew E Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1355-61. PubMed ID: 3091527 [TBL] [Abstract][Full Text] [Related]
6. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology]. Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337 [TBL] [Abstract][Full Text] [Related]
8. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous immune rejection of intraocular tumors in mice. Niederkorn JY; Meunier PC Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853 [TBL] [Abstract][Full Text] [Related]
10. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224 [TBL] [Abstract][Full Text] [Related]
11. Population dynamics of T lymphocytes. Renewal rate and expansion in the peripheral lymphoid organs. Rocha B; Freitas AA; Coutinho AA J Immunol; 1983 Nov; 131(5):2158-64. PubMed ID: 6605376 [TBL] [Abstract][Full Text] [Related]
12. Thymectomized, irradiated, and bone marrow-reconstituted chimeras have normal cytolytic T lymphocyte precursors but a defect in lymphokine production. Duprez V; Maziarz R; Weinberger O; Burakoff SJ J Immunol; 1984 May; 132(5):2185-9. PubMed ID: 6232313 [TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice. Sabzevari H; Reisfeld RA Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution. Ma J; Urba WJ; Si L; Wang Y; Fox BA; Hu HM Eur J Immunol; 2003 Aug; 33(8):2123-32. PubMed ID: 12884286 [TBL] [Abstract][Full Text] [Related]
15. T cell repopulation from functionally restricted splenic progenitors: 10,000-fold expansion documented by using limiting dilution analyses. Miller RA; Stutman O J Immunol; 1984 Dec; 133(6):2925-32. PubMed ID: 6238091 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity. Lee FH; Currie D; Hwang KM Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997 [TBL] [Abstract][Full Text] [Related]
17. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype. Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782 [TBL] [Abstract][Full Text] [Related]
18. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations. Schwartz A; Gershon RK J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894 [TBL] [Abstract][Full Text] [Related]
19. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. Li Y; McGowan P; Hellström I; Hellström KE; Chen L J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929 [TBL] [Abstract][Full Text] [Related]
20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]